Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.
Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading institutions across the ...
Radiotherapy (also called radiation therapy), a commonly used cancer treatment that uses high-energy radiation, can effectively eliminate or shrink various types of tumors. While radiotherapy benefits ...
The value of pelvic lymph node irradiation is debated for patients with muscle-invasive bladder cancer (MIBC) undergoing curative-intent radiation therapy (RT). We sought to compare the oncologic ...
A patient who will be referred to as Ms. L in this case study was 34 years old when she presented to the emergency department in January 2012 with severe pain in the right lower quadrant that radiated ...
Please provide your email address to receive an email when new articles are posted on . The PROSPECT trial showed FOLFOX to be noninferior to pelvic chemoradiation before surgery with regard to DFS.
SAN FRANCISCO, September 29, 2025 — Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results ...
You may also experience more general side effects of radiotherapy such as sore skin and tiredness. Read more about the general side effects of radiotherapy Like all side effects of radiotherapy, you ...
We report the clinical outcomes of a randomized trial comparing prophylactic whole-pelvic nodal radiotherapy to prostate-only radiotherapy (PORT) in high-risk prostate cancer. This phase III, single ...
This phase III, single center, randomized controlled trial enrolled eligible patients undergoing radical radiotherapy for node-negative prostate adenocarcinoma, with estimated nodal risk ≥ 20%.
Radiation enteritis is inflammation of the intestines that may occur in people undergoing radiation therapy. It is more common in people receiving radiotherapy on the abdomen, rectum, and pelvis.